Loss of Striatal [76Br]Bromospiperone Binding Sites Demonstrated by Positron Tomography in Progressive Supranuclear Palsy

[1]  D Comar,et al.  Crossed cerebellar diaschisis. Further studies. , 1986, Brain : a journal of neurology.

[2]  E. Hirsch,et al.  Dopaminergic and cholinergic lesions in progressive supranuclear palsy , 1985, Annals of neurology.

[3]  S. Luthra,et al.  NEW LABELLED LIGAND FOR IN-VIVO STUDIES OF OPIOID PHYSIOLOGY , 1985, The Lancet.

[4]  J. Baron,et al.  In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone. , 1985, European journal of pharmacology.

[5]  T Greitz,et al.  Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Y. Agid,et al.  PROGRESSIVE SUPRANUCLEAR PALSY: LOSS OF STRIATAL DOPAMINE RECEPTORS DEMONSTRATED IN VIVO BY POSITRON TOMOGRAPHY , 1985, The Lancet.

[7]  J. Mazziotta,et al.  Positron emission tomography: human brain function and biochemistry. , 1985, Science.

[8]  J S Fowler,et al.  [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. , 1985, Life sciences.

[9]  D Comar,et al.  Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.

[10]  C. D. Arnett,et al.  Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography , 1985, Journal of neurochemistry.

[11]  Dean F. Wong,et al.  Imaging Opiate Receptors in the Human Brain by Positron Tomography , 1985, Journal of computer assisted tomography.

[12]  Dopaminergic receptor sites in human brain , 1985, Neurology.

[13]  G. di Chiro,et al.  Atlas of Dopamine Receptor Images (PET) of the Human Brain , 1985, Journal of computer assisted tomography.

[14]  D Comar,et al.  Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[16]  A. Wolf,et al.  Mapping brain neuroleptic receptors in the live baboon. , 1984, Biological psychiatry.

[17]  R. Naquet,et al.  76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors. , 1984, Life sciences.

[18]  L. C. Murrin,et al.  Dopamine Receptors: Effects of Chronic L‐Dopa and Bromocriptine Treatment in an Animal Model of Parkinson's Disease , 1984, Clinical neuropharmacology.

[19]  A. Syrota,et al.  Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography. , 1984, Life sciences.

[20]  D. Brooks,et al.  PRE-SYNAPTIC AND POST-SYNAPTIC DOPAMINERGIC SYSTEM IN HUMAN BRAIN , 1984, The Lancet.

[21]  Y. Agid,et al.  [3H]spiperone binding in the nigrostriatal system in human brain. , 1984, European journal of pharmacology.

[22]  Y Agid,et al.  [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. , 1984, European journal of pharmacology.

[23]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[24]  F. Soussaline,et al.  Physical characterization of a time-of-flight positron emission tomography system for whole-body quantitative studies , 1984 .

[25]  O. DeJesus,et al.  Measurements in vivo of parameters of the dopamine system , 1984, Annals of neurology.

[26]  M. Mintun,et al.  Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. , 1983, Life sciences.

[27]  T. Crow,et al.  DOPAMINE RECEPTORS DISPLAYED IN LIVING HUMAN BRAIN WITH 77Br-p-BROMOSPIPERONE , 1983, The Lancet.

[28]  Jonathan M. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography , 1983 .

[29]  T. Crow,et al.  77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors. , 1983, Life sciences.

[30]  J. C. Stoof.  Dopamine Receptors in the Neostriatum: Biochemical and Physiological Studies , 1983 .

[31]  C. D. Arnett,et al.  Specific Binding of [11C]Spiroperidol in Rat Brain In Vivo , 1983, Journal of neurochemistry.

[32]  T. Ban,et al.  Central nervous system receptors in neuropsychiatric disorders , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  J. Marcusson,et al.  Age‐Correlated Loss of Dopaminergic Binding Sites in Human Basal Ganglia , 1982, Journal of neurochemistry.

[34]  J. Mazziotta,et al.  TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE , 1981 .

[35]  J. Mazziotta,et al.  Tomographic mapping of human cerebral metabolism , 1981, Neurology.

[36]  H. K. Kulmala,et al.  Specific in vivo binding of 77Br-p-bromospiroperidol in rat brain: a potential tool for gamma ray imaging. , 1981, Life sciences.

[37]  H. Meltzer,et al.  Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug. , 1980, Journal of pharmaceutical sciences.

[38]  M E Phelps,et al.  Positron emission tomography. , 1979, Medical instrumentation.

[39]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. , 1978, Biochemical pharmacology.

[40]  A. Herz,et al.  The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain , 1977, Brain Research.

[41]  J. Steele.  Progressive supranuclear palsy. , 1972, Brain : a journal of neurology.